Support the news

Billions at Stake in Boston Scientific-Guidant Deal

This article is more than 13 years old.

Shareholders at Guidant and Boston Scientific will vote at the end of March on the pending mega-union of the two companies. It has been a rocky road since Boston Scientific agreed to buy Guidant for $27 billion. Stacey Vanek Smith explores what's at stake.

This program aired on March 15, 2006. The audio for this program is not available.

+Join the discussion

Support the news